Not all aging cells die when they should. Some enter a state called cellular senescence, where they stop dividing but refuse to undergo programmed cell death. Scientists sometimes call these "zombie cells" because they persist in tissues, consuming resources without contributing to normal function.
These dysfunctional cells release a cocktail of inflammatory molecules known as the senescence-associated secretory phenotype (SASP). According to research from the Mayo Clinic, SASP factors can induce senescence in neighboring healthy cells, spreading dysfunction throughout tissues.3 The inflammatory burden created by accumulating senescent cells has been linked to numerous age-related conditions.
Cellular senescence initially serves a protective function by stopping damaged cells from dividing. Problems arise when these cells accumulate over decades. The body's immune system normally clears senescent cells, but this clearance mechanism becomes less efficient with age, leading to a growing burden of dysfunctional cells.
The Interconnected Nature of Cellular Aging
These three pathways do not operate in isolation. They influence and amplify each other in ways that accelerate decline:
- Oxidative stress depletes NAD+ by activating PARP repair enzymes that consume it during DNA repair.
- Low NAD+ impairs antioxidant defenses, as sirtuins require NAD+ to regulate stress response genes.
- Both oxidative stress and NAD+ depletion can trigger cellular senescence.
- Senescent cells generate additional free radicals, perpetuating the cycle.
This interconnection explains why targeting all three pathways simultaneously may offer advantages over addressing any single hallmark alone. A comprehensive approach to cellular health considers each of these mechanisms and their relationships to one another.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare provider before beginning any supplement regimen.
References:
1. Kumar, P., Osahon, O. W., & Bhattacharya, P. K. (2023). Glycine and N‑acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition. The Journals of Gerontology: Series A, 78(1), 75–89.
2. Camacho‑Pereira, J., Tarragó, M. G., Chini, C. C. S., Nin, V., Escande, C., Warner, G. M., Puranik, A. S., Schoon, R. A., Reid, J. M., Galina, A., & Chini, E. N. (2016). CD38 dictates age‑related NAD decline and mitochondrial dysfunction through an SIRT3‑dependent mechanism. Cell Metabolism, 23(6), 1127–1139.
3. Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., Onken, J. L., Johnson, K. O., Verzosa, G. C., Langhi Prata, L. G. P., Stout, M. B., Giorgadze, N., Jensen, M. D., LeBrasseur, N. K., & Kirkland, J. L. (2018). Senolytics improve physical function and increase lifespan in old age. Nature Medicine, 24(8), 1246–1256.
